Barclays’s Hims & Hers Health HIMS Stock Holding History
Bought
Maintained
Sold
Other funds holding HIMS
VPM
VCM
DE
Barclays's HIMS Position: Q1 2026 in Review
Barclays reduced its Hims & Hers Health (HIMS) stake by 33% in Q1 2026, selling an estimated $7.42M and leaving 639,372 shares worth $13.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1307.
Barclays first reported a position in HIMS in Q1 2022 and has held it in 17 quarters since. The position peaked at $37.4M in Q3 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.
- Barclays held 639,372 shares of Hims & Hers Health worth $13.3M as of Q1 2026.
- Barclays sold 314,099 Hims & Hers Health shares in Q1 2026, an estimated $7.42M.
- Hims & Hers Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1307 holding.
- Barclays first reported a position in Hims & Hers Health in Q1 2022 and has held it in 17 quarters since.
- Barclays's Hims & Hers Health position peaked at $37.4M in Q3 2025.
- 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.